Panagora Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Sell |
3,408
-77
| -2% | -$35.9K | 0.01% | 632 |
|
|
2025
Q4 | $1.58M | Buy |
3,485
+77
| +2% | +$33.2K | 0.01% | 624 |
|
|
2025
Q3 | $1.33M | Hold |
3,408
| – | – | 0.01% | 601 |
|
|
2025
Q2 | $1.52M | Sell |
3,408
-11
| -0.3% | -$5.07K | 0.01% | 544 |
|
|
2025
Q1 | $1.66M | Sell |
3,419
-6
| -0.2% | -$2.8K | 0.01% | 558 |
|
|
2024
Q4 | $1.38M | Sell |
3,425
-9,910
| -74% | -$4.59M | 0.01% | 589 |
|
|
2024
Q3 | $6.2M | Sell |
13,335
-35,219
| -73% | -$16.9M | 0.03% | 313 |
|
|
2024
Q2 | $22.8M | Sell |
48,554
-51,616
| -52% | -$22.4M | 0.11% | 147 |
|
|
2024
Q1 | $41.9M | Sell |
100,170
-133,961
| -57% | -$56.6M | 0.22% | 113 |
|
|
2023
Q4 | $95.3M | Buy |
234,131
+32,612
| +16% | +$12M | 0.53% | 45 |
|
|
2023
Q3 | $70.1M | Buy |
201,519
+105,608
| +110% | +$36.9M | 0.44% | 58 |
|
|
2023
Q2 | $33.8M | Buy |
95,911
+60,495
| +171% | +$20.4M | 0.2% | 124 |
|
|
2023
Q1 | $11.2M | Sell |
35,416
-75,526
| -68% | -$22.7M | 0.07% | 245 |
|
|
2022
Q4 | $32M | Buy |
110,942
+34,885
| +46% | +$10.6M | 0.21% | 120 |
|
|
2022
Q3 | $22M | Sell |
76,057
-22
| -0% | -$6.33K | 0.15% | 154 |
|
|
2022
Q2 | $21.4M | Sell |
76,079
-108,918
| -59% | -$29.2M | 0.14% | 166 |
|
|
2022
Q1 | $48.3M | Sell |
184,997
-89,263
| -33% | -$21.2M | 0.26% | 90 |
|
|
2021
Q4 | $60.2M | Sell |
274,260
-115,628
| -30% | -$22.5M | 0.32% | 67 |
|
|
2021
Q3 | $70.7M | Buy |
389,888
+90,980
| +30% | +$17.8M | 0.38% | 55 |
|
|
2021
Q2 | $60.3M | Buy |
298,908
+71,477
| +31% | +$15M | 0.32% | 63 |
|
|
2021
Q1 | $48.9M | Buy |
227,431
+185,337
| +440% | +$40.7M | 0.27% | 78 |
|
|
2020
Q4 | $9.95M | Sell |
42,094
-49,947
| -54% | -$11.5M | 0.06% | 280 |
|
|
2020
Q3 | $25M | Buy |
92,041
+14,368
| +18% | +$3.96M | 0.16% | 141 |
|
|
2020
Q2 | $22.5M | Buy |
77,673
+97
| +0.1% | +$26.3K | 0.14% | 143 |
|
|
2020
Q1 | $18.5M | Sell |
77,576
-553
| -0.7% | -$127K | 0.13% | 163 |
|
|
2019
Q4 | $17.1M | Sell |
78,129
-182,691
| -70% | -$37M | 0.08% | 249 |
|
|
2019
Q3 | $44.2M | Sell |
260,820
-478,708
| -65% | -$84.7M | 0.2% | 118 |
|
|
2019
Q2 | $136M | Sell |
739,528
-116,764
| -14% | -$20.4M | 0.61% | 36 |
|
|
2019
Q1 | $158M | Sell |
856,292
-479,597
| -36% | -$88.6M | 0.7% | 24 |
|
|
2018
Q4 | $221M | Sell |
1,335,889
-118,675
| -8% | -$20.6M | 1.03% | 15 |
|
|
2018
Q3 | $280M | Buy |
1,454,564
+499,019
| +52% | +$88.9M | 1.06% | 12 |
|
|
2018
Q2 | $162M | Buy |
955,545
+73,360
| +8% | +$11.4M | 0.64% | 28 |
|
|
2018
Q1 | $144M | Buy |
882,185
+61,554
| +8% | +$10.1M | 0.57% | 37 |
|
|
2017
Q4 | $123M | Buy |
820,631
+62,303
| +8% | +$9.23M | 0.46% | 44 |
|
|
2017
Q3 | $115M | Buy |
758,328
+145,142
| +24% | +$21.8M | 0.46% | 46 |
|
|
2017
Q2 | $79M | Buy |
613,186
+163,633
| +36% | +$19.7M | 0.32% | 72 |
|
|
2017
Q1 | $49.2M | Sell |
449,553
-447
| -0.1% | -$39.4K | 0.2% | 118 |
|
|
2016
Q4 | $33.2M | Buy |
450,000
+18,064
| +4% | +$1.47M | 0.15% | 145 |
|
|
2016
Q3 | $37.7M | Sell |
431,936
-4,337
| -1% | -$410K | 0.18% | 124 |
|
|
2016
Q2 | $37.5M | Sell |
436,273
-12,639
| -3% | -$1.09M | 0.19% | 113 |
|
|
2016
Q1 | $35.7M | Sell |
448,912
-6,766
| -1% | -$612K | 0.18% | 126 |
|
|
2015
Q4 | $57.3M | Sell |
455,678
-184
| -0% | -$22.2K | 0.28% | 86 |
|
|
2015
Q3 | $47.5M | Buy |
455,862
+44,757
| +11% | +$5.75M | 0.25% | 99 |
|
|
2015
Q2 | $50.8M | Buy |
411,105
+28,519
| +7% | +$3.59M | 0.25% | 92 |
|
|
2015
Q1 | $45.1M | Buy |
382,586
+33,919
| +10% | +$4.06M | 0.23% | 112 |
|
|
2014
Q4 | $41.4M | Buy |
348,667
+121,717
| +54% | +$13.7M | 0.21% | 124 |
|
|
2014
Q3 | $25.5M | Buy |
226,950
+199,610
| +730% | +$19M | 0.12% | 177 |
|
|
2014
Q2 | $2.59M | Sell |
27,340
-6,397
| -19% | -$449K | 0.01% | 727 |
|
|
2014
Q1 | $2.39M | Buy |
33,737
+13,109
| +64% | +$1.04M | 0.01% | 810 |
|
|
2013
Q4 | $1.53M | Buy |
20,628
+3,803
| +23% | +$265K | 0.01% | 987 |
|
|
2013
Q3 | $1.28M | Sell |
16,825
-12,306
| -42% | -$979K | 0.01% | 1012 |
|
|
2013
Q2 | $2.33M | Buy |
+29,131
| New | +$2.15M | 0.01% | 727 |
|
Other funds holding VRTX
VCM
VPM
Panagora Asset Management's VRTX Position: Q1 2026 in Review
Panagora Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q1 2026, selling an estimated $35.9K and leaving 3,408 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #632.
Panagora Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $280M in Q3 2018. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Panagora Asset Management held 3,408 shares of Vertex Pharmaceuticals worth $1.52M as of Q1 2026.
- Panagora Asset Management sold 77 Vertex Pharmaceuticals shares in Q1 2026, an estimated $35.9K.
- Vertex Pharmaceuticals made up 0.01% of Panagora Asset Management's portfolio in Q1 2026, its #632 holding.
- Panagora Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Panagora Asset Management's Vertex Pharmaceuticals position peaked at $280M in Q3 2018.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.